Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2010
10/07/2010WO2010114143A1 System for increasing activity of specific promoter, and vector carrying the system
10/07/2010WO2010114129A1 T cell receptor and nucleic acid encoding the receptor
10/07/2010WO2010113925A1 Composition for alleviating ultraviolet radiation-induced damage
10/07/2010WO2010113906A1 Met inhibitor comprising ephedrae herba
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113844A1 Rnai molecule for thymidylate synthase and use thereof
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113725A1 Tricyclic condensed heterocyclic compound, method for producing same, and use thereof
10/07/2010WO2010113495A1 C6orf167 peptides and vaccines containing the same
10/07/2010WO2010113458A1 Method for manufacturing benzodiazepine derivative
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112656A1 Compounds stimulating undesirable cellular adhesion and applications thereof
10/07/2010WO2010112510A1 Use of flavonoids to increase the bioavailability of hesperetin
10/07/2010WO2010112413A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/07/2010WO2010112124A1 Autotaxin inhibitors
10/07/2010WO2010112116A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010WO2010112110A1 Anti-icam-1 antibody, uses and methods
10/07/2010WO2010111910A1 Synthetic peptide and uses thereof
10/07/2010WO2010111891A1 Modified oligo-nucleic acid molecule, preparation method and uses thereof
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010111807A1 A polysaccharide liposome, the preparation method and use of it
10/07/2010WO2010111792A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
10/07/2010WO2010111746A1 Anti-vegf-d antibodies
10/07/2010WO2010094009A3 Methods and compositions for the treatment of ras associated disorders
10/07/2010WO2010092571A3 Short beta-defensin-derived peptides
10/07/2010WO2010072843A3 Use of a peptide derived from er-alpha for restoring sensitivity to antiestrogenic compounds in breast tumour cells
10/07/2010WO2010065824A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/07/2010WO2010064851A3 Mtor-targeted sirna having an interspecific cross reaction, recombination vector containing same, and pharmaceutical composition containing same
10/07/2010WO2010063470A9 Methods for preventing or reducing colon carcinogenesis
10/07/2010WO2010062506A3 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
10/07/2010WO2010055072A3 Treating cancer by modulating a mnk
10/07/2010WO2010048623A9 Medical and imaging nanoclusters
10/07/2010WO2010043866A3 Histone lysine demethylase inhibitors
10/07/2010WO2010042225A3 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides
10/07/2010WO2010039825A3 Imidazo [1, 2-a] pyridine compounds as receptor tyrosine kinase inhibitors
10/07/2010WO2009109388A8 Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation
10/07/2010WO2009105969A8 Epothilone analogues, their pharmaceutical compositions, their use and their preparations
10/07/2010US20100256401 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
10/07/2010US20100256240 Prostacyclin derivatives
10/07/2010US20100256232 Cancer Therapy
10/07/2010US20100256230 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
10/07/2010US20100256227 Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor
10/07/2010US20100256225 Constructs containing multiple expression cassettes for cancer therapy
10/07/2010US20100256223 Oligonucleotides for modulating target rna activity
10/07/2010US20100256218 RNAi MODULATION OF MLL-AF4 AND USES THEREOF
10/07/2010US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor
10/07/2010US20100256200 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
10/07/2010US20100256189 Piperidine derivative
10/07/2010US20100256180 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
10/07/2010US20100256177 Flavopereirine derivatives for cancer therapy
10/07/2010US20100256172 Heteroaryls and uses thereof
10/07/2010US20100256171 Selective serine/threonine kinase inhibitors
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256168 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
10/07/2010US20100256167 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
10/07/2010US20100256166 Novel Hydantoin Derivatives as Metalloproteinase Inhibitors
10/07/2010US20100256164 Pseudobase benzo[c]phenantridines with improved efficacy, stability and safety
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256160 Method of administering an antitumor compound
10/07/2010US20100256158 Polymorphs of dasatinib and process for preparation thereof
10/07/2010US20100256155 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds
10/07/2010US20100256149 Novel arylamino n-heteraryl compounds as mek inhibitors
10/07/2010US20100256148 Use of cfms inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer
10/07/2010US20100256147 Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256143 Pharmaceutical compounds
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256137 Indazolamide derivatives
10/07/2010US20100256136 Method for Enhancing Pdt Efficacy Using a Tyrosine Kinase Inhibitor
10/07/2010US20100256133 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256118 Novel adenine compound and use thereof
10/07/2010US20100256115 Inhibitors of iap
10/07/2010US20100256110 Pharmaceutical solid dispersions
10/07/2010US20100256098 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods
10/07/2010US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp
10/07/2010US20100256085 Toll-Like Receptor Agonist Regulation of VEGF-Induced Tissue Responses
10/07/2010US20100256081 Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
10/07/2010US20100256076 Compositions and Methods Related to Calcitriol
10/07/2010US20100256075 High Yield Secretion of Multimeric Recombinant Protein
10/07/2010US20100256073 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2
10/07/2010US20100256072 Therapeutic agents for the treatment of leukemia
10/07/2010US20100256071 CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
10/07/2010US20100256069 Targeted induction of aggregation of proteins with cross beta structures
10/07/2010US20100256068 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
10/07/2010US20100256046 Treatment of proliferative disorders
10/07/2010US20100256043 Use of a peptide as a therapeutic agent
10/07/2010US20100256041 Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
10/07/2010US20100255538 Antibodies to insulin-like growth factor i receptor
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255130 Aloe preparation for skin enhancement
10/07/2010US20100255129 Herbal composition phy906 and its use in chemotherapy
10/07/2010US20100255126 Medicament for treatment of cancer and other diseases
10/07/2010US20100255117 Methods and compositions for the treatment of cancer
10/07/2010US20100255110 Functional agricultural product and method for cultivating the same
10/07/2010US20100255108 Combination Treatment of Cancer With Cetuximab and Tetrac
10/07/2010US20100255106 Benzothiophenes, formulations containing same, and methods
1 ... 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 ... 2211